6 Dimensions Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Tamarind Biotamarind.bioin𝕏Series A · Feb 2026 · $14M
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US
Deniz Kavi(Co-founder & CEO)inSherry Liu(Founder)in
Co-investorsTranspose Platform ManagementTreeo VCY Combinator468 CapitalDimension CapitalEight Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







